Origami Therapeutics, Inc.
San Diego, USA
|
Description:
Origami Therapeutics is a preclinical-stage company developing novel protein degrader therapeutics with a proprietary drug discovery platform which holds the promise for disease-modification in neurodegenerative diseases such as Huntington's disease. The company plans to generate a pipeline of small molecule therapeutics that prevent or delay the onset and the progression of neurodegenerative diseases to improve the quality of patients’ lives.
Origami Therapeutics is a preclinical-stage company developing novel protein degrader therapeutics with a proprietary drug discovery platform which holds the promise for disease-modification in neurodegenerative diseases such as Huntington's disease. The company plans to generate a pipeline of small molecule therapeutics that prevent or delay the onset and the progression of neurodegenerative diseases to improve the quality of patients’ lives.